Global Respiratory Virus Infection Drugs Market to Flourish at 7% CAGR, Crossing US$ 82.8 Billion by 2030: TMR Report
02 juin 2023 05h46 HE
|
Transparency Market Research
Wilmington, Delaware, United States, June 02, 2023 (GLOBE NEWSWIRE) -- The global respiratory virus infection drugs market is projected to flourish at a CAGR of nearly 7% from 2022 to 2030. As per...